Skip to main content
. 2014 Sep 7;20(33):11753–11761. doi: 10.3748/wjg.v20.i33.11753

Figure 5.

Figure 5

4-hydroxynonenal immunohistostaining comparing control, non-alcoholic fatty liver disease, and osthol groups (A-D). The NAFLD group shows increased 4-hydroxynonenal (4-HNE) immunohistostaining compared with the osthol group. NAFLD: Non-alcoholic fatty liver disease.